|
Real-time Estimate
Cboe BZX
22:13:42 10/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 33.66 USD | -0.34% |
|
-9.13% | -10.10% |
| 11-05 | Deutsche Bank Adjusts Harmony Biosciences Price Target to $38 From $42, Maintains Hold Rating | MT |
| 11-05 | Harmony Biosciences Holdings, Inc., Q3 2026 Earnings Call, Nov 04, 2026 |
| Market Cap | 1.98B 1.78B 1.64B 1.49B 2.82B 186B 2.9B 19.63B 7.82B 99.65B 7.44B 7.29B 315B | P/E 2026 * |
9.23x | P/E 2027 * | 8.34x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27B 1.14B 1.05B 954M 1.81B 119B 1.86B 12.58B 5.01B 63.85B 4.77B 4.67B 202B | EV / Sales 2026 * |
1.24x | EV / Sales 2027 * | 0.8x |
| Free-Float |
96.6% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HRMY | Delayed | |
CBOE
| HRMY | Real-time | |
|
Mexican S.E.
| HRMY * | End-of-day quote |
Last Transcript: Harmony Biosciences Holdings, Inc.
| 1 day | -0.34% | ||
| 1 week | -9.13% | ||
| Current month | -13.21% | ||
| 1 month | -12.01% | ||
| 3 months | -13.74% | ||
| 6 months | +11.46% | ||
| Current year | -10.10% |
| 1 week | 32.27 |  | 35.97 |
| 1 month | 32.27 | | 39.89 |
| Current year | 25.9 | | 43.49 |
| 1 year | 25.9 | | 43.49 |
| 3 years | 23.42 | | 43.49 |
| 5 years | 18.61 | | 62.08 |
| 10 years | 18.61 | | 62.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 68 | 06/01/2023 |
| Director of Finance/CFO | - | 16/07/2026 | |
Kumar Budur
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeffrey Aronin
CHM | Chairman | 58 | 25/07/2017 |
Juan Sabater
BRD | Director/Board Member | 61 | 01/01/2017 |
Andreas Wicki
BRD | Director/Board Member | 66 | 01/09/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/09/26 | Exercice | Chief Technology Officer | 107,556 | 0.1847% | ||
| 08/09/26 | Sell | Chief Technology Officer | -74,362 | 0.1277% | ||
| 16/07/26 | Other | Chief Financial Officer | 62,991 | 0.1088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | -9.13% | +5.72% | +41.46% | 1.98B | |
| +0.78% | +0.90% | +47.12% | +137.93% | 1,258B | |
| -0.35% | +5.64% | +49.23% | +90.95% | 679B | |
| +0.06% | +2.65% | +34.24% | +111.84% | 518B | |
| +0.17% | +2.76% | +44.07% | +69.71% | 390B | |
| -1.31% | +1.31% | +68.95% | +44.55% | 367B | |
| +0.76% | +2.27% | +31.59% | +60.36% | 307B | |
| -1.29% | +0.90% | +5.77% | +37.60% | 293B | |
| -0.31% | +0.55% | +43.30% | +73.51% | 252B | |
| +0.33% | +1.32% | +43.61% | +123.50% | 210B | |
| Average | -0.10% | -0.14% | +37.36% | +79.14% | 428B | |
| Weighted average by Cap. | +0.09% | +1.17% | +43.13% | +96.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.03B 922M 850M 772M 1.46B 96.4B 1.5B 10.18B 4.05B 51.65B 3.86B 3.78B 163B | 1.18B 1.06B 973M 884M 1.67B 110B 1.72B 11.65B 4.64B 59.13B 4.42B 4.32B 187B |
| Net income | 230M 206M 190M 173M 327M 21.55B 336M 2.28B 906M 11.55B 863M 844M 36.51B | 253M 227M 209M 190M 359M 23.71B 369M 2.5B 997M 12.71B 949M 929M 40.17B |
| Net Debt | -713M -639M -589M -535M -1.01B -66.81B -1.04B -7.05B -2.81B -35.8B -2.67B -2.62B -113B | -1.04B -934M -861M -782M -1.48B -97.64B -1.52B -10.31B -4.11B -52.31B -3.91B -3.83B -165B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | $33.62 | -0.49% | 221,526 |
| 09/11/26 | $33.78 | +2.02% | 792,930 |
| 06/11/26 | $33.11 | +1.97% | 787,173 |
| 05/11/26 | $32.47 | -5.65% | 1,477,534 |
| 04/11/26 | $34.42 | -7.04% | 2,469,409 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HRMY Stock
Select your edition
All financial news and data tailored to specific country editions
